Table 1 Patient characteristics
BPCTrea patients N = 302 | Procalcivir patients N = 73 | |||
|---|---|---|---|---|
Without pneumonia N = 177 | With pneumonia N = 125 | Without pneumonia N = 39 | With pneumonia N = 34 | |
Age (years), mean ± SD | 67 ± 10 | 70 ± 11 | 62 ± 15 | 70 ± 10 |
Men n (%) | 126 (71) | 82 (66) | 26 (67) | 28 (82) |
Current smoker n (%) | 76 (43) | 38 (30) | 11 (28) | 11 (32) |
Comorbidities | ||||
Arterial hypertension n (%) | 83 (47) | 73 (58) | 15 (38) | 17 (50) |
Cardiopathy n (%) | 61 (34) | 44 (35) | 8 (15) | 23 (67) |
Diabetes mellitus n (%) | 30 (17) | 29 (23) | 13 (33) | 13 (38) |
Severity of COPD n (%) | ||||
GOLD stage 0–I | 15 (8) | 9 (7) | 7 (18) | 2 (6) |
GOLD stage II | 18 (10) | 29 (23) | 3 (8) | 9 (26) |
GOLD stage III | 58 (33) | 33 (26) | 3 (8) | 3 (9) |
GOLD stage IV | 69 (39) | 42 (34) | 26 (67) | 20 (59) |
GOLD stage unknown | 12 (7) | 17 (14) | – | – |
Home oxygen n (%) | 74 (42) | 53 (42) | 22 (56) | 18 (53) |
Home noninvasive ventilatory support n (%) | 42 (24) | 32 (25) | 5 (13) | 6 (18) |
Severity of illness | ||||
SAPS II, median (Q1–Q3) | 32 (26-41) | 38 (30-46) | 30 (23–35) | 37 (20–50) |
Pneumonia severity index class n (%) | ||||
I–III | 43 (34) | 4 (11) | ||
IV | 15 (12) | 14 (42) | ||
V | 67 (54) | 16 (47) | ||
Mechanical ventilation at the time of inclusion n (%) | ||||
Invasive n (%) | 45 (25) | 37 (30) | 6 (15) | 14 (41) |
Noninvasive n (%) | 108 (61) | 74 (60) | 25 (64) | 20 (58) |
Antibiotics at the time of inclusion n (%) | 93 (53) | 89 (71) | 9 (23) | 11 (32) |
Documented infection n (%) | ||||
Bacterial | 36 (20) | 38 (30) | 5 (13) | 15 (44) |
Viral | 38 (21) | 28 (22) | 9 (23) | 5 (15) |
PCT H0 (μg/L), median ((Q1-Q3) | 0.16 (0.08–0.49) | 0.42 (0.14–0.86) | 0.10 (0.07–0.18) | 0.49 (0.13–1.47) |